Vertex Pharmaceuticals | Kapitalizacja Rynkowa



Market Capitalization Zmiana Data
AbbVie USD 347.61B 23.02B 2025-05
Agios Pharmaceuticals USD 1.76B 109M 2025-05
Alnylam Pharmaceuticals USD 33.57B 1.55B 2025-05
Amgen USD 150.06B 10.09B 2025-05
Arrowhead Research USD 2.34B 69M 2024-12
Biogen USD 17.89B 4.39B 2025-05
BioMarin Pharmaceutical USD 11.72B 824M 2025-05
Bristol-Myers Squibb USD 101.45B 22.65B 2025-05
Gilead Sciences USD 129.47B 10.21B 2025-05
Incyte USD 13.94B 2.22B 2025-05
Insmed USD 12.38B 676M 2024-12
Ionis Pharmaceuticals USD 4.78B 14M 2025-05
J&J USD 374.87B 24.78B 2025-05
Merck USD 212.34B 13.54B 2025-05
Moderna USD 10.56B 396M 2025-05
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 137.09B 6.62B 2025-05
PTC Therapeutics USD 3.51B 653M 2024-12
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Sanofi EUR 122.48B 3.37B 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
United Therapeutics USD 13.91B 17M 2025-05
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Vertex Pharmaceuticals Kapitalizacja Rynkowa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.